ArticleAdvances in therapy2022

Real-World Safety and Effectiveness of Canagliflozin Treatment for Type 2 Diabetes Mellitus in Japan: SAPPHIRE, a Long-Term, Large-Scale Post-Marketing Surveillance.

Nobuya Inagaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.